Toll Free Phone:
1-866-892-2032; 
[email protected]
Servicing Healthcare Professionals and Companies
We Accept:
Free Shipping After: $1000
Never Overpay Again    |   5% First Order Discount   |   No Order Minimum   |   Free Replacement on Delays
Free Shipping After: $1000

REVOLAX™ is a CE-marked Korean hyaluronic acid dermal filler range developed by Across Co., Ltd. for aesthetic practitioners working across the full spectrum of facial correction — from superficial fine lines to deep structural volumization. The three-product portfolio — REVOLAX™ Fine, REVOLAX™ Deep, and REVOLAX™ Sub-Q — covers distinct injection planes, with each variant available with or without lidocaine to accommodate different patient and practice preferences. Licensed practitioners can buy REVOLAX™ from Medica Depot at wholesale prices with group purchase options and verified LOT traceability. Browse the product list to compare REVOLAX™ filler variants or contact our team for bulk pricing and availability.


FDA Approved

REVOLAX™

REVOLAX DEEP LIDOCAINE 01
REVOLAX FINE LIDOCAINE 01
Short Dated Available
OUTLET
REVOLAX SUBQ LIDOCAINE 01.jpg

REVOLAX™ Technology and Manufacturer — Across Co., Ltd.

REVOLAX™ is manufactured by Across Co., Ltd., a South Korean company focused on HA-based aesthetic medical devices [1]. The company develops its dermal filler products using proprietary cross-linking and purification processes and manufactures them under conditions that meet both South Korea’s Ministry of Food and Drug Safety (MFDS) regulatory requirements and CE marking requirements for European and international markets [1].

The “highly purified” designation that accompanies REVOLAX™ reflects specific manufacturing standards: the cross-linked HA is produced through bacterial fermentation rather than animal-derived sources, which removes one category of hypersensitivity risk, and the purification process is designed to minimize residual BDDE cross-linking agent to levels consistent with CE-mark regulatory thresholds [1]. The resulting gel is monophasic — cross-linked and free HA fractions form a single cohesive phase rather than a particulate suspension — which contributes to smooth tissue integration and predictable injection behavior across all three viscosity grades [1]. Hyaluronic acid is well established in aesthetic medicine as a biocompatible, biodegradable material capable of attracting and retaining water within soft tissues; cross-linking extends its in-tissue longevity well beyond that of non-cross-linked HA [2].

Durability varies by product and it is important to understand the length of each treatment effect before you buy REVOLAX™. For example, REVOLAX™ Fine is formulated for superficial correction and typically maintains results for approximately 6–9 months. REVOLAX™ Deep and REVOLAX™ Sub-Q, placed at greater tissue depths where metabolic turnover is slower, are expected to provide correction for approximately 12–18 months under typical clinical conditions, though individual longevity depends on treatment area, injection volume, and patient-specific factors [1]. Practitioners looking to buy HA dermal fillers will find REVOLAX™ among the more competitively priced CE-marked options within that category.

Buy REVOLAX™ Wholesale — Full Product Range Across Three Viscosity Grades

REVOLAX™ Fine addresses the superficial dermis — glabellar lines, periorbital fine lines, forehead wrinkles, and selected neck wrinkles that require a low-viscosity gel placed close to the surface without risk of visible product [1]. Its low cross-linking density suits the mechanics of thin, mobile skin where a denser filler would behave poorly.

REVOLAX™ Deep moves into the mid-to-deep dermis for nasolabial folds, marionette lines, lip augmentation, and cheek contouring. It carries the highest clinical demand in the REVOLAX™ range — REVOLAX™ Deep lip filler applications in particular have driven significant practitioner interest, given the product’s balance of projection and moldability at lip injection depths [1].

REVOLAX™ Sub-Q is the highest-viscosity formulation, designed for subcutaneous and supraperiosteal placement in areas requiring what the manufacturer describes as aesthetic implant-depth support — chin augmentation, jawline definition, and structural cheekbone enhancement where the product must resist deformation and maintain projection over time [1]. It is the appropriate choice when practitioners need to indirectly reduce nasolabial folds through skeletal-level support rather than treating the folds directly.

Every formulation is available with integrated 0.3% lidocaine for practitioners who prefer to manage patient comfort without a separate anesthetic step, or without lidocaine where clinical protocol requires it.

Other Popular REVOLAX™ Products — Full Comparison for Practitioners

REVOLAX™ Fine is the superficial correction formulation, suited to fine wrinkles and delicate treatment zones where a lower-viscosity gel is clinically appropriate. It is the entry point for practitioners new to the range and the standard choice for periorbital and glabellar fine-line work [1].

REVOLAX™ Fine with Lidocaine offers the same HA formulation with integrated 0.3% lidocaine, reducing procedural discomfort in sensitive areas. It is particularly useful for periorbital treatments where topical anesthesia alone may be insufficient [1].

REVOLAX™ Deep is the most widely used product in the range, handling nasolabial fold correction, lip augmentation, and cheek contouring with the gel cohesivity and projection suited to mid-to-deep dermal placement. Practitioners who select a REVOLAX™ deep filler for lips typically appreciate its moldability and reduced immediate post-treatment swelling compared with higher-viscosity alternatives [1].

REVOLAX™ Deep with Lidocaine incorporates lidocaine into the standard Deep formulation for multi-zone treatment sessions where repeated injections warrant built-in anesthesia rather than supplemental nerve block [1].

REVOLAX™ Sub-Q is intended for deep structural work at subcutaneous and supraperiosteal levels — chin projection, jawline definition, and cheekbone augmentation where the gel must hold its shape under the mechanical pressures of underlying muscle activity [1].

REVOLAX™ Sub-Q with Lidocaine covers the same deep volumization indications with added lidocaine to reduce procedural discomfort at the longer injection points that supraperiosteal placement often requires [1].

Browse the selection above to buy REVOLAX™ online today.

Treatment Areas and Clinical Indications to Know Before You Buy REVOLAX™ Online

REVOLAX™ Fine is most commonly selected for glabellar lines, periorbital fine lines, forehead wrinkles, and superficial neck wrinkles where a lightweight gel placed intradermally can smooth surface texture without adding detectable volume [1].

REVOLAX™ Deep handles the mid-face workhorse indications: nasolabial fold correction, marionette line treatment, lip augmentation, and cheek contouring [1]. Lip filler practitioners who use REVOLAX™ Deep for augmentation typically inject at the vermilion border and body of the lip at standard HA lip injection depths, relying on the product’s cohesivity to define shape without migration.

REVOLAX™ Sub-Q is reserved for deep facial volumization — the chin, jawline, and lateral cheekbone region — where structural support at subcutaneous or supraperiosteal depth produces the contouring effect practitioners would otherwise achieve with an implant. Because it sits at this depth, it requires familiarity with deep injection anatomy and aspiration technique before injecting [1].

Administration and Injection Technique

Injection depth follows the viscosity hierarchy: REVOLAX™ Fine is placed at the superficial dermal level, REVOLAX™ Deep at the mid-to-deep dermal level, and REVOLAX™ Sub-Q at the subcutaneous or supraperiosteal level [1]. Practitioners should aspirate before injecting, particularly in vascular risk areas, and follow current clinical safety guidance for HA filler administration regardless of which REVOLAX™ variant is in use [5].

Lidocaine-containing variants eliminate the need for a separate field block or topical anesthesia step in most treatment contexts, though some practitioners prefer non-lidocaine presentations for protocols involving pre-procedure nerve block. Post-treatment, standard HA filler aftercare applies: patients should avoid excessive heat exposure, strenuous physical activity, and prolonged UV exposure for approximately 24–48 hours following injection [1].

Regulatory Status – Check Before You Order REVOLAX™ online

REVOLAX™ holds CE mark certification under EU Medical Device Regulation and MFDS approval in South Korea [1]. It is not currently FDA-cleared or FDA-approved for distribution or use in the United States [4] — practitioners considering REVOLAX™ for their US-based practice should verify applicable import and administration regulations before purchasing. Outside the US, REVOLAX™ is available through authorized international distributors, including Medica Depot, which supplies licensed practitioners with verified, traceable product sourced through confirmed distribution channels [1].

Why Practitioners Choose REVOLAX™

REVOLAX™’s range consolidation (Fine, Deep, and Sub-Q) covers every standard injection depth, from superficial fine-line correction to structural facial volumization, which means a single brand relationship covers a practice’s full HA filler needs without requiring practitioners to become familiar with multiple product handling profiles [1]. Switching between REVOLAX™ variants within a session is more straightforward than switching between brands, and inventory management is simplified when a single brand covers most indications.

Moreover, its cost-to-credential ratio is one reason practitioners choose it. REVOLAX™ combines CE-marked quality standards and dual MFDS/CE regulatory approval with the competitive wholesale pricing typically supported by Korean manufacturing [1]. For practices running high-volume filler programs where cost per syringe affects treatment margins, REVOLAX™ offers a documented regulatory pedigree at a price point that European-manufactured alternatives with equivalent CE marking often cannot match.

For practices planning to buy Korean dermal fillers, REVOLAX™’s three-tier depth structure makes it a natural addition to an existing Korean filler formulary.

REVOLAX™ vs Competing HA Dermal Fillers

Medica Depot has been selling the REVOLAX™ filler range for many years, enough to understand, from experience with real customers, how it compares against competing hyaluronic acid fillers.

REVOLAX™ vs DERMALAX™

REVOLAX™ and DERMALAX™ are both Korean hyaluronic acid filler brands that offer multiple formulations intended for different treatment depths. Both product families are used for wrinkle correction, contour enhancement, and volume restoration, with product selection guided by practitioner preference and treatment objectives.

One distinguishing characteristic of REVOLAX™ is its streamlined three-product structure consisting of Fine, Deep, and Sub-Q variants. This simplified portfolio can make product selection straightforward for practitioners who prefer a limited number of options covering a broad range of indications.

Practitioners evaluating both brands typically make the call based on handling characteristics, regional availability, and familiarity with the respective manufacturing approaches. Those who buy DERMALAX™ at Medica Depot alongside REVOLAX™ can compare both Korean HA portfolios within the same procurement account.

REVOLAX™ vs NEURAMIS®

NEURAMIS® is a Korean HA filler with a broader product line than REVOLAX™’s three variants, including formulations targeting specific indications such as skin hydration and fine-surface rejuvenation, as well as structural-correction products. Practitioners who prioritize a wider selection of viscosity grades and indication-specific products tend to buy NEURAMIS® when they want more granular control over product-to-indication matching than a three-tier system provides. REVOLAX™, by contrast, suits practices that want a lean, depth-mapped system rather than a comprehensive catalog.

REVOLAX™ vs BELLAST®

BELLAST® is a Korean HA filler with a strong focus on high-viscosity volumizing applications, making the most meaningful comparison with REVOLAX™ Sub-Q specifically rather than the full three-product range. Where REVOLAX™ Sub-Q is designed for chin, jawline, and cheekbone structural work, BELLAST® is similarly positioned for patients requiring substantial deep-plane volume. Clinics that want to assess how the two handle at supraperiosteal depth can buy BELLAST® through Medica Depot and run both alongside each other. These products share a treatment depth but differ in gel cohesivity and post-injection tissue behavior.

REVOLAX™ vs REVOFIL

REVOFIL incorporates formulations that extend beyond standard cross-linked HA filler positioning into skin-quality and hydration-focused applications, broadening its clinical scope relative to REVOLAX™’s focused correction-and-contour approach. Practitioners who want a single brand covering both structural filler and biorevitalizing functions may find this distinction relevant when deciding whether to buy REVOFIL for practices that currently source those two categories separately — it adds a dimension that REVOLAX™’s three-tier system does not cover.

REVOLAX™ vs INTRALINE®

INTRALINE® is distributed internationally across multiple aesthetic product categories and spans a range of HA filler formulations targeting standard wrinkle correction and volumization indications. Its CE-marking and international distribution make it a comparable option to REVOLAX™ in terms of regulatory credentials. The clinical selection between them tends to come down to injector familiarity and which brand’s viscosity profile matches a given patient’s tissue characteristics — factors practitioners usually assess through hands-on experience rather than specifications alone. Clinics ready to make that comparison can buy INTRALINE® at Medica Depot and evaluate it directly against REVOLAX™ within the same ordering workflow.

REVOLAX™ vs PERFECTHA®

PERFECTHA® is a European-manufactured HA filler range — developed in France — placing it in a different manufacturing context from Korean-origin REVOLAX™, despite both holding CE marking. Its product line covers fine, deep, and volume correction tiers in a structure that parallels REVOLAX™’s depth-based range, but the cross-linking chemistry and resulting gel mechanics differ between the two. For practitioners who prioritize European origin in procurement decisions, buy PERFECTHA® through Medica Depot offers a like-for-like structural alternative across the same treatment-depth range — the comparison ultimately comes down to handling preference and sourcing origin rather than indication coverage.

REVOLAX™ Safety Profile — Adverse Events and Contraindications

Adverse events reported with cross-linked HA fillers as a class are well characterized in the clinical literature [3]. Injection-site reactions — redness, localized swelling, tenderness, bruising, and mild itching — are the most commonly reported effects and are generally transient, resolving within several days as tissue recovers from the injection procedure [3]. Results from controlled clinical evaluation of HA fillers in nasolabial fold correction confirm that treatment-related reactions at injection sites are typically mild and short-lived [2].

Less common adverse events include palpable nodules, delayed inflammatory reactions, hypersensitivity responses, and infection [3]. The risk of these events is reduced through careful patient screening, strict aseptic technique, and correct product-to-depth matching. Serious complications, including vascular occlusion and tissue ischemia, can occur with any dermal filler administered in anatomically complex regions; practitioners should maintain familiarity with facial vascular anatomy, aspirate before injecting in high-risk zones, and have hyaluronidase available for emergency management [5]. The FDA notes that serious complications from dermal fillers, while uncommon, require trained injectors who can recognize early warning signs and respond appropriately [5].

Contraindications include known hypersensitivity to hyaluronic acid or any of its components [1]. For lidocaine-containing variants, confirmed lidocaine allergy is an additional contraindication. Treatment should be postponed in any area affected by active infection, inflammation, or active skin disease until the condition has resolved. Pregnancy and breastfeeding are standard contraindications for elective HA filler procedures; practitioners should review the full manufacturer IFU and assess each patient individually before proceeding [1].

At Medica Depot, you can buy REVOLAX™ wholesale with full LOT traceability, verified distribution documentation, and group purchasing options for multi-practitioner practices. Browse the product list above to order REVOLAX™ online and add directly to cart, or contact our team for bulk pricing suited to your clinic’s ordering cycle. Practices consolidating filler sourcing can also buy dermal fillers across a broader range of brands through the same platform.

Frequently Asked Questions About REVOLAX™

What is REVOLAX™?

REVOLAX™ is a CE-marked range of Korean hyaluronic acid dermal fillers manufactured by Across Co., Ltd. The portfolio covers three viscosity grades — Fine, Deep, and Sub-Q — each available with or without 0.3% lidocaine, designed to address facial correction from superficial fine lines through to deep structural volumization [1]. Practitioners can buy each REVOLAX™ filler online at medica Depot.

What is the difference between REVOLAX™ Fine, Deep, and Sub-Q?

The distinction is injection depth and gel viscosity. REVOLAX™ Fine is a low-viscosity gel for superficial intradermal placement — fine lines, glabellar lines, and periorbital correction. REVOLAX™ Deep is a mid-viscosity product for the mid-to-deep dermis — nasolabial folds, lip augmentation, and cheek contouring. REVOLAX™ Sub-Q is the highest-viscosity formulation, placed at subcutaneous or supraperiosteal depth for chin, jawline, and structural cheekbone work [1].

How long does REVOLAX™ last?

REVOLAX™ Fine typically maintains results for approximately 6–9 months. REVOLAX™ Deep and REVOLAX™ Sub-Q are expected to provide correction for approximately 12–18 months, with longevity varying by treatment area, injection volume, and individual patient metabolism [1]. Clinical evidence for HA fillers in comparable indications supports this general durability range [2].

Is REVOLAX™ FDA-approved?

No. REVOLAX™ is not currently FDA-cleared or FDA-approved for the US market [4]. It holds CE mark certification under EU Medical Device Regulation and MFDS approval in South Korea. Practitioners considering REVOLAX™ for US-based patients should verify applicable import and administration regulations before purchasing.

How does REVOLAX™ compare to JUVÉDERM®?

Both are cross-linked HA filler systems but differ in origin, manufacturing chemistry, and price positioning. JUVÉDERM® uses Allergan’s proprietary VYCROSS or HYLACROSS cross-linking technology and holds FDA approval for specific US indications. REVOLAX™ is a Korean-manufactured CE-marked alternative at a more competitive wholesale price point, without current FDA clearance [1][4]. For practices outside the US where regulatory availability is equivalent, the clinical comparison comes down to gel handling, viscosity preference, and cost per syringe for each indication.

What is REVOLAX™ Sub-Q used for?

REVOLAX™ Sub-Q is designed for deep facial volumization at subcutaneous and supraperiosteal depths — chin augmentation, jawline enhancement, and structural cheekbone contouring [1]. It functions at the manufacturer-described aesthetic implant depth, providing structural projection and contour support that lower-viscosity HA fillers cannot achieve at standard dermal injection planes.

Can REVOLAX™ Fine be used for lip filler?

REVOLAX™ Fine is not the indicated choice for lip augmentation — its low viscosity and superficial placement profile are suited to fine-line correction rather than lip body augmentation, which requires the gel cohesivity and projection capacity of REVOLAX™ Deep [1]. Practitioners who look for a REVOLAX™ lip filler should use REVOLAX™ Deep or REVOLAX™ Deep with Lidocaine, which is formulated for the mid-dermal injection depth used in standard lip augmentation technique.

Where can licensed practitioners order REVOLAX™ wholesale?

Medica Depot stocks the full REVOLAX™ range — Fine, Deep, and Sub-Q, with and without lidocaine — for licensed aesthetic practitioners with competitive wholesale pricing, group-buy options, verified LOT traceability, and fast shipping. Add directly to cart from the product list above or contact our team for volume pricing support as you order REVOLAX™ wholesale.

Disclaimer

The contents of this page are meant for licensed medical professionals. They serve informational purposes only and are not to be taken as medical advice.

Citations and Resources about REVOLAX™

[1] Across Co., Ltd. REVOLAX™. Across Co., Ltd. 2017. https://across.kr/eng/sub/sub02_03.php

[2] Cho JY, Kim SH, Cho H, et al. Noninferiority Study Comparing the Efficacy and Safety of a New Hyaluronic Acid (HA) Filler Containing Lidocaine With an Existing HA Filler for the Treatment of Nasolabial Fold Wrinkles: A Randomized, Double-Blind, Split-Face Trial. Journal of Cosmetic Dermatology. 2025. https://pubmed.ncbi.nlm.nih.gov/40620129/

[3] Kyriazidis I, Spyropoulou GA, Zambacos G, et al. Adverse Events Associated with Hyaluronic Acid Filler Injection for Non-surgical Facial Aesthetics: A Systematic Review of High Level of Evidence Studies. Aesthetic Plastic Surgery. 2024. https://pubmed.ncbi.nlm.nih.gov/37563436/

[4] U.S. Food and Drug Administration. FDA-Approved Dermal Fillers. FDA. Updated 2020. https://www.fda.gov/medical-devices/aesthetic-cosmetic-devices/fda-approved-dermal-fillers

[5] U.S. Food and Drug Administration. Dermal Fillers (Soft Tissue Fillers). FDA. Updated 2023. https://www.fda.gov/medical-devices/aesthetic-cosmetic-devices/dermal-fillers-soft-tissue-fillers

Written by the Medica Depot Editorial Staff

This content was prepared and reviewed under our editorial guidelines , which govern how we source, verify, and update clinical and product information. Every claim is checked against peer-reviewed research, manufacturer documentation, or regulatory guidance before publication.

Choosing the right products starts with confidence in their authenticity. At Medica Depot, we prioritize genuine branded products, reliable sourcing, and quality you can trust. Explore our standards and learn more about how we ensure product authenticity.

Cart (0)

No products in the cart.

Continue shopping